Zhejiang Jingxin Pharmaceutical Co., Ltd. (SHE:002020)

China flag China · Delayed Price · Currency is CNY
14.86
-0.27 (-1.78%)
Apr 28, 2026, 3:04 PM CST
Market Cap12.09B -1.9%
Revenue (ttm)4.00B -6.6%
Net Income712.56M -1.2%
EPS0.86 +2.1%
Shares Out813.76M
PE Ratio17.33
Forward PE14.15
Dividend0.35 (2.31%)
Ex-Dividend DateMay 29, 2025
Volume12,481,400
Average Volume13,521,223
Open15.10
Previous Close15.13
Day's Range14.81 - 15.47
52-Week Range12.79 - 22.62
Beta-0.01
RSI39.01
Earnings DateApr 24, 2026

About SHE:002020

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products and medical devices in China and internationally. The company offers antihypertensive, antibiotics, quinolones, gastrointestinal promotion, antidiabetic, antiepileptic, antihistamine, H+ pump depressant, antihyper cholesterolemia, histamine H2 receptor blockader, antihyper cholesterolemirs, antidepressant, cephalosporin, and biopharma products; and API products, including ciprofloxacin, ciprofloxacin hydrochloride, ciprofloxacin lactat... [Read more]

Sector Healthcare
Founded 1990
Employees 3,869
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002020
Full Company Profile

Financial Performance

In 2024, SHE:002020's revenue was 4.16 billion, an increase of 3.99% compared to the previous year's 4.00 billion. Earnings were 711.96 million, an increase of 15.04%.

Financial Statements